This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.
Approval for a transfer of a portion of the manufacturing operations for the bulk solutions of reagents r1 and r2, as well as bulk solutions of pretreatment reagents to newly constructed manufacturing space.
| Device | ELECSYS ANTI-HCV ON COBAS E 411 |
| Classification Name | Assay, Enzyme Linked Immunosorbent, Hepatitis C Virus |
| Generic Name | Assay, Enzyme Linked Immunosorbent, Hepatitis C Virus |
| Applicant | ROCHE DIAGNOSTICS CORP. |
| Date Received | 2012-01-31 |
| Decision Date | 2012-12-20 |
| PMA | P090007 |
| Supplement | S007 |
| Product Code | MZO |
| Advisory Committee | Microbiology |
| Supplement Type | 135 Review Track For 30-day Notice |
| Expedited Review | No |
| Combination Product | No |
| Applicant Address | ROCHE DIAGNOSTICS CORP. 9115 Hague Rd. indianapolis, IN 46250 |
| Supplement Number | Date | Supplement Type |
|---|---|---|
| P090007 | Original Filing | |
| S020 | 2018-10-26 | Normal 180 Day Track No User Fee |
| S019 | 2018-03-01 | Real-time Process |
| S018 | ||
| S017 | 2017-10-11 | Real-time Process |
| S016 | 2017-08-03 | 30-day Notice |
| S015 | 2016-02-16 | 30-day Notice |
| S014 | 2016-01-27 | 30-day Notice |
| S013 | 2015-10-07 | 30-day Notice |
| S012 | 2014-08-22 | 30-day Notice |
| S011 | 2012-11-30 | 30-day Notice |
| S010 | 2012-09-05 | 30-day Notice |
| S009 | ||
| S008 | 2012-02-29 | 30-day Notice |
| S007 | 2012-01-31 | 135 Review Track For 30-day Notice |
| S006 | 2011-11-21 | 30-day Notice |
| S005 | 2011-08-29 | 135 Review Track For 30-day Notice |
| S004 | 2011-08-17 | 135 Review Track For 30-day Notice |
| S003 | 2011-05-17 | Normal 180 Day Track No User Fee |
| S002 | 2011-04-11 | 30-day Notice |
| S001 | 2010-07-28 | Normal 180 Day Track |